CELLBXHEALTH EUROPE LIMITED

• ⚠

  Material uncertainty over going concern

  ANGLE plc has reported a material uncertainty in its financial statements that may cast significant doubt about its ability to provide the financial support to ANGLE Europe Limited as and when required. These conditions, along with the other matters explained in note 1.4 to the financial statements, indicate the existence of a material uncertainty which may cast significant doubt about the company's ability to continue as a going concern. The financial statements do not include any adjustments that would result if the company were unable to continue as a going concern.

• ◆

  4 officer resignations in last 12 months

  Multiple officers have left the board recently — see the People section for who.

1. CELLBXHEALTH EUROPE LIMITED 2025-10-08 → present
2. ANGLE EUROPE LIMITED 2015-04-14 → 2025-10-08
3. PARSORTIX LIMITED 2013-06-07 → 2015-04-14
4. ANGLE VENTURES LIMITED 2006-04-26 → 2013-06-07

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

IFRS

Reporting scope

Standalone (parent only)

Auditor

PricewaterhouseCoopers LLP

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“ANGLE plc has reported a material uncertainty in its financial statements that may cast significant doubt about its ability to provide the financial support to ANGLE Europe Limited as and when required. These conditions, along with the other matters explained in note 1.4 to the financial statements, indicate the existence of a material uncertainty which may cast significant doubt about the company's ability to continue as a going concern. The financial statements do not include any adjustments that would result if the company were unable to continue as a going concern.”

Group structure

1. CELLBXHEALTH EUROPE LIMITED · parent
   1. ANGLE EU BV · The Netherlands · to overcome Brexit logistics issues and facilitate the fulfilment of EU wide product sales.
   2. ANGLE North America Inc.
   3. ANGLE Biosciences Inc.

Significant events

• “In the second half of the year, operations were streamlined to concentrate on collaborations with large pharma and biotechnology companies, aiming to leverage the Parsortix system and assays to enhance drug discovery and development. This strategic realignment has not only optimised the use of resources but has also positioned ANGLE for sustainable growth.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

13

last 12 months

Capital events

0

last 24 months

Officers appointed

3

last 12 months

Officers resigned

4

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +31.6%

  £1,821,000 → £2,396,000

• Cash

  +5.6%

  £1,001,000 → £1,057,000

• Net assets

  -13.4%

  -£105,089,000 → -£119,195,000

• Employees

  0%

  126 → 126

• Operating profit

  +17.8%

  -£19,703,000 → -£16,196,000

• Profit before tax

  +17.7%

  -£19,872,000 → -£16,363,000

• Wages

  +3.8%

  £6,143,000 → £6,376,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers